Skip to main content
. 2012 Dec 18;7(12):e52025. doi: 10.1371/journal.pone.0052025

Table 3. Summary of lifetime use of cannabis and stimulants in the ecstasy (E), amphetamine (A), and cannabis (C) groups.

Stimulants
Subject Cannabis Ecstasy Amphetamine Total
E1 1529 153 3 156
E2 4380 52 5 57
E3 1456 20 2 22
E4 15 18 1 19
E5 2763 13 4 17
E6 72 9 3 12
E7 183 6 1 7
E8 60 5 1 6
E9 450 5 1 6
E mean (SD) 1212 (1512) 31 (48) 2 (2) 34 (49)
A1 13 1 832 833
A2 7365 3 244 247
A3 6570 1 208 209
A4 360 4 231 235
A5 212 5 92 97
A6 270 1 26 27
A7 4384 0 7 7
A mean (SD) 2739 (3275) 2 (2) 234 (281) 236 (281)
C1 8395
C2 1248
C3 364
C4 154
C5 130
C6 104
C7 92
C8 80
C9 64
C10 39
C11 9
C12 6
C mean (SD) 890 (2388)

Single subject data are presented (number of times used) and the mean±standard deviation for each group. The term ‘amphetamine’ describes amphetamine and amphetamine-like drugs such methamphetamine, cocaine, dexamphetamine, and methylphenidate. The term ‘ecstasy’ describes ecstasy and MDA (3,4-methylenedioxyamphetamine, 2 subjects).